Research and treatment related to suicide prevention for veterans and patients with bipolar depression or PTSD.
2025 · 4th Quarter (Oct 1 - Dec 31)
NRX PHARMACEUTICALS INC (FORMERLY KNOWN AS NEURORX)
Filed by TWENTY-FIRST CENTURY GROUP, INC..
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 19, 2026
- Income
- $24,000.00
- Expenses
- Not reported
- Registrant
- TWENTY-FIRST CENTURY GROUP, INC.
- Filing UUID
- 23f8fb4f-2c75-4cc3-818f-0cf636422b96
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Research and treatment related to suicide prevention for veterans and patients with bipolar depression or PTSD.
Research and treatment related to suicide prevention for veterans and patients with bipolar depression or PTSD.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.